Status:

COMPLETED

Protein Ingestion and Skeletal Muscle Atrophy

Lead Sponsor:

University of Exeter

Conditions:

Muscle Atrophy

Eligibility:

MALE

18-35 years

Phase:

NA

Brief Summary

The effect of different protein intakes on skeletal muscle atrophy during short term unilateral leg immobilisation.

Eligibility Criteria

Inclusion

  • BMI \>18 and \<28 no prescription medications or current illness.

Exclusion

  • BMI \<18 and \>28 current prescription medication no history of leg injury.
  • Smoker
  • Medical conditions including (cardiovascular disease ((e.g. hypertension)), metabolic disease ((e.g. type 2 diabetes)), any personal or family history of deep vein thrombosis.

Key Trial Info

Start Date :

October 31 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2019

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT03797781

Start Date

October 31 2017

End Date

December 31 2019

Last Update

September 28 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sport and Health Science

Exeter, Devon, United Kingdom, EX1 2LU

Protein Ingestion and Skeletal Muscle Atrophy | DecenTrialz